Showing posts with label VT 1129. Show all posts
Showing posts with label VT 1129. Show all posts

Wednesday 29 March 2017

QUILSECONAZOLE, VT 1129, New Patent, WO, 2017049080, Viamet


str1
VT 1129 BENZENE SULFONATE
CAS 1809323-18-9

Image result for VT1129

VT 1129

1340593-70-5 CAS
MF C22 H14 F7 N5 O2, MW 513.37
2-Pyridineethanol, α-(2,4-difluorophenyl)-β,β-difluoro-α-(1H-tetrazol-1-ylmethyl)-5-[4-(trifluoromethoxy)phenyl]-, (αR)-
R ISOMER
ROTATION +
QUILSECONAZOLE, VT-1129
Viamet, in collaboration with Therapeutics for Rare and Neglected diseases, is investigating quilseconazole benzenesulfonate (VT-1129), a small-molecule lanosterol demethylase (CYP51) inhibitor, developed using the company's Metallophile technology, for treating fungal infections, including Cryptococcus neoformans meningitis.
WO-2017049080
  

////////////QUILSECONAZOLE, VT-1129, New Patent, WO, 2017049080, Viamet